Breast Cancer Drug - Global Market Outlook (2017-2026)

Breast Cancer Drug - Global Market Outlook (2017-2026)

  • Published: July 2019
  • ID: SMRC18440

According to Stratistics MRC, the Global Breast Cancer Drug Market is accounted for $14.75 billion in 2017 and is expected to reach $43.27 billion by 2026 growing at a CAGR of 12.7% during the forecast period. High prevalence of breast cancer, growing R&D investments and rising healthcare expenditure and awareness are some of the key factors influence market growth. However, stringent regulatory guidelines and expiry of patented drugs is restraining the market growth.
 
Breast cancer is most commonly diagnosed cancer in women worldwide and also is one of the leading causes of death. Breast cancer is a disease where uncontrolled growth of malignant cells in the breast tissue that is most commonly occurs in female than men. Breast cancer is the result of uncontrolled cell division of breast cells, most commonly cells of breast lobule and ducts.

Based on Drug, Chemotherapy Drugs segment growth is due to development in the fields of drug delivery and oncology, and increased government funding and initiative to create awareness about cancer diagnosis and treatment. By Geography, North America is going to have a lucrative growth due to prevalence of chronic diseases, growing focus of global pharmaceutical companies in this region.

Some of the key players profiled in the Breast cancer drug Market include Novartis AG, Celgene Corporation, Janssen Global Services LLC, Onyx Pharmaceuticals Inc., AbbVie, Inc., Eli Lilly and Company, Celldex Therapeutics, BioNumerik Pharmaceuticals, Inc., AstraZeneca, Merck & Co., Inc., Genzyme Corporation, MacroGenics, Inc., F. Hoffmann-La Roche Ltd. and Biocon.

Procedures Covered:
• Mitotic inhibitor
• Aromatase inhibitor
• Hormonal rec
• HER2 inhibitor
• Anti-metabolites
• CDK 4/6 inhibitor

Drugs Covered:
• Targeted Therapy Drugs
• Chemotherapy Drugs
• Hormone Therapy Drugs
• Other Drugs
 
Distribution Channels Covered:
• Clinics 
• Online Pharmacies 
• Ambulatory Surgical centers 
• Hospitals 
• Retail Pharmacies
 
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand      
o South Korea       
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary    
      
2 Preface     
 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
      
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats    
 3.6 Emerging Markets   
 3.7 Futuristic Market Scenario  
      
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes  
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
      
5 Global Breast Cancer Drug Market, By Type 
 5.1 Introduction   
 5.2 Mitotic Inhibitor   
 5.3 Aromatase Inhibitor  
 5.4 Hormonal rec   
 5.5 HER2 Inhibitor   
 5.6 Anti-Metabolites   
 5.7 CDK 4/6 Inhibitor   
      
6 Global Breast Cancer Drug Market, By Drug 
 6.1 Introduction   
 6.2 Targeted Therapy Drugs  
  6.2.1 Ado-Trastuzumab Emtansine 
  6.2.2 Neratinib   
  6.2.3 Monoclonal Antibodies (mAbs)
   6.2.3.1 Bevacizumab 
   6.2.3.2 Trastuzumab 
   6.2.3.3 Other Monoclonal Antibodies (mAbs)
  6.2.4 Lapatinib   
  6.2.5 Tyrosine kinase inhibitors 
 6.3 Chemotherapy Drugs  
  6.3.1 Antimetabolites  
   6.3.1.1 Capecitabine 
   6.3.1.2 Gemcitabine 
   6.3.1.3 Fluorouracil 
  6.3.2 Anthracyclines  
   6.3.2.1 Epirubicin 
   6.3.2.2 Doxorubicin 
  6.3.3 Alkylating Agents   
  6.3.4 Neoadjuvant Chemotherapy 
  6.3.5 Adjuvant Chemotherapy 
  6.3.6 Taxanes   
   6.3.6.1 Docetaxel 
   6.3.6.2 Paclitaxel 
  6.3.7 Advanced Breast Cancer 
  6.3.8 Epothilones  
 6.4 Hormone Therapy Drugs  
  6.4.1 Ecstasy and Related Drug (ERD)
  6.4.2 Selective Estrogen-Receptor Modulators (SERMs)
   6.4.2.1 Tamoxifen 
   6.4.2.2 Toremifene 
   6.4.2.3 Raloxifene 
  6.4.3 Aromatase Inhibitors 
   6.4.3.1 Anastrozole 
   6.4.3.2 Letrozole  
   6.4.3.3 Megestrol 
  6.4.5 Luteinising Hormone-Releasing Hormone
  6.4.6 Other Hormonal Therapies 
   6.4.6.1 Goserelin Acetate 
   6.4.6.2 Fulvestrant 
   6.4.6.3 Fluoxymesterone 
 6.5 Other Drugs   
      
7 Global Breast Cancer Drug Market, By Distribution Channel
 7.1 Introduction   
 7.2 Clinics    
 7.3 Online Pharmacies   
 7.4 Ambulatory Surgical Centers  
 7.5 Hospitals    
 7.6 Retail Pharmacies   
      
8 Global Breast Cancer Drug Market, By Geography   
 8.1 Introduction     
 8.2 North America     
  8.2.1 US     
  8.2.2 Canada     
  8.2.3 Mexico     
 8.3 Europe      
  8.3.1 Germany     
  8.3.2 UK     
  8.3.3 Italy     
  8.3.4 France     
  8.3.5 Spain     
  8.3.6 Rest of Europe    
 8.4 Asia Pacific     
  8.4.1 Japan     
  8.4.2 China     
  8.4.3 India     
  8.4.4 Australia     
  8.4.5 New Zealand    
  8.4.6 South Korea    
  8.4.7 Rest of Asia Pacific    
 8.5 South America     
  8.5.1 Argentina    
  8.5.2 Brazil     
  8.5.3 Chile     
  8.5.4 Rest of South America   
 8.6 Middle East & Africa    
  8.6.1 Saudi Arabia    
  8.6.2 UAE     
  8.6.3 Qatar     
  8.6.4 South Africa    
  8.6.5 Rest of Middle East & Africa     
      
9 Vendor Landscaping   
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
 9.2 Acquisitions & Mergers  
 9.3 New Product Launch  
 9.4 Expansions   
 9.5 Other Key Strategies  
      
10 Company Profiles    
 10.1 Novartis AG   
 10.2 Celgene Corporation  
 10.3 Janssen Global Services LLC  
 10.4 Onyx Pharmaceuticals Inc.  
 10.5 AbbVie, Inc.   
 10.6 Eli Lilly and Company  
 10.7 Celldex Therapeutics  
 10.8 BioNumerik Pharmaceuticals, Inc. 
 10.9 AstraZeneca   
 10.10 Merck & Co., Inc.   
 10.11 Genzyme Corporation  
 10.12 MacroGenics, Inc.   
 10.13 F. Hoffmann-La Roche Ltd.  
 10.14 Biocon


List of Tables     
1 Global Breast Cancer Drug Market Outlook, By Region (2016-2026)(US $MN) 
2 Global Breast Cancer Drug Market Outlook, By Type (2016-2026)(US $MN) 
3 Global Breast Cancer Drug Market Outlook, By Mitotic Inhibitor (2016-2026)(US $MN) 
4 Global Breast Cancer Drug Market Outlook, By Aromatase Inhibitor (2016-2026)(US $MN) 
5 Global Breast Cancer Drug Market Outlook, By Hormonal rec (2016-2026)(US $MN) 
6 Global Breast Cancer Drug Market Outlook, By HER2 Inhibitor (2016-2026)(US $MN) 
7 Global Breast Cancer Drug Market Outlook, By Anti-Metabolites (2016-2026)(US $MN) 
8 Global Breast Cancer Drug Market Outlook, By CDK 4/6 Inhibitor (2016-2026)(US $MN) 
9 Global Breast Cancer Drug Market Outlook, By Drug (2016-2026)(US $MN) 
10 Global Breast Cancer Drug Market Outlook, By Targeted Therapy Drugs (2016-2026)(US $MN) 
11 Global Breast Cancer Drug Market Outlook, By Ado-Trastuzumab Emtansine (2016-2026)(US $MN) 
12 Global Breast Cancer Drug Market Outlook, By Neratinib (2016-2026)(US $MN) 
13 Global Breast Cancer Drug Market Outlook, By Monoclonal Antibodies (mAbs) (2016-2026)(US $MN) 
14 Global Breast Cancer Drug Market Outlook, By Lapatinib (2016-2026)(US $MN) 
15 Global Breast Cancer Drug Market Outlook, By Tyrosine kinase inhibitors (2016-2026)(US $MN) 
16 Global Breast Cancer Drug Market Outlook, By Chemotherapy Drugs (2016-2026)(US $MN) 
17 Global Breast Cancer Drug Market Outlook, By Antimetabolites (2016-2026)(US $MN) 
18 Global Breast Cancer Drug Market Outlook, By Anthracyclines (2016-2026)(US $MN) 
19 Global Breast Cancer Drug Market Outlook, By Alkylating Agents (2016-2026)(US $MN) 
20 Global Breast Cancer Drug Market Outlook, By Neoadjuvant Chemotherapy (2016-2026)(US $MN) 
21 Global Breast Cancer Drug Market Outlook, By Adjuvant Chemotherapy (2016-2026)(US $MN) 
22 Global Breast Cancer Drug Market Outlook, By Taxanes (2016-2026)(US $MN) 
23 Global Breast Cancer Drug Market Outlook, By Advanced Breast Cancer (2016-2026)(US $MN) 
24 Global Breast Cancer Drug Market Outlook, By Epothilones (2016-2026)(US $MN) 
25 Global Breast Cancer Drug Market Outlook, By Hormone Therapy Drugs (2016-2026)(US $MN) 
26 Global Breast Cancer Drug Market Outlook, By Ecstasy and Related Drug (ERD) (2016-2026)(US $MN) 
27 Global Breast Cancer Drug Market Outlook, By Selective Estrogen-Receptor Modulators (SERMs) (2016-2026)(US $MN) 
28 Global Breast Cancer Drug Market Outlook, By Aromatase Inhibitors (2016-2026)(US $MN) 
29 Global Breast Cancer Drug Market Outlook, By Luteinising Hormone-Releasing Hormone (2016-2026)(US $MN) 
30 Global Breast Cancer Drug Market Outlook, By Other Hormonal Therapies (2016-2026)(US $MN) 
31 Global Breast Cancer Drug Market Outlook, By Distribution Channel (2016-2026)(US $MN) 
32 Global Breast Cancer Drug Market Outlook, By Clinics (2016-2026)(US $MN) 
33 Global Breast Cancer Drug Market Outlook, By Online Pharmacies (2016-2026)(US $MN) 
34 Global Breast Cancer Drug Market Outlook, By Ambulatory Surgical Centers (2016-2026)(US $MN) 
35 Global Breast Cancer Drug Market Outlook, By Hospitals (2016-2026)(US $MN) 
36 Global Breast Cancer Drug Market Outlook, By Retail Pharmacies (2016-2026)(US $MN) 
      
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials